Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 6, keine Gesamtzahl für „treated“
Suchtreffer
Begriffe & Kennungen
Amgevita · 4.8 · 21 (95% confidence interval) of lymphomas was 0.7 (0.2, 2.7) per 1,000 patient-years among adalimumab-treated
Eintrag öffnenAmgevita · 4.8 · In the pivotal controlled trials in adults and children, 12.9% of patients treated with adalimumab developed i
Eintrag öffnenAmgevita · 4.8 · In the pivotal controlled trials in adults and children, 12.9% of patients treated with adalimumab developed i
Eintrag öffnenAmgevita · 4.8 · Rare post-marketing cases of hepatosplenic T-cell lymphoma have been reported in patients treated with adalimu
Eintrag öffnenAmgevita · 4.8 · Rare post-marketing cases of hepatosplenic T-cell lymphoma have been reported in patients treated with adalimu
Eintrag öffnenAmgevita · 4.8 · The incidence of serious infections was 0.04 per patient year in adalimumab-treated patients and 0.03 per pati
Eintrag öffnenAmgevita · 4.8 · The incidence of serious infections was 0.04 per patient year in adalimumab-treated patients and 0.03 per pati
Eintrag öffnenAmgevita · 4.8 · The safety profile for patients with HS treated with adalimumab weekly was consistent with the known safety pr
Eintrag öffnenAmgevita · 4.8 · The safety profile for patients with HS treated with adalimumab weekly was consistent with the known safety pr
Eintrag öffnenAmgevita · 4.8 · The safety profile for patients with uveitis treated with adalimumab every other week was consistent with the
Eintrag öffnenAmgevita · 4.8 · The safety profile for patients with uveitis treated with adalimumab every other week was consistent with the
Eintrag öffnenAmglidia · 4.8 · The following adverse effects have been observed in adult patients treated with other products containing glib
Eintrag öffnenAmsparity · 4.8 · 105 non-melanoma skin cancers was 8.8 (6.0, 13.0) per 1,000 patient-years among adalimumab-treated patients an
Eintrag öffnenAmsparity · 4.8 · In the pivotal controlled trials in adults and children, 12.9% of patients treated with adalimumab developed i
Eintrag öffnenAmsparity · 4.8 · In the pivotal controlled trials in adults and children, 12.9% of patients treated with adalimumab developed i
Eintrag öffnenAmsparity · 4.8 · In the pivotal controlled trials in adults and children, 12.9% of patients treated with adalimumab developed i
Eintrag öffnenAmsparity · 4.8 · Rare post-marketing cases of hepatosplenic T-cell lymphoma have been reported in patients treated with adalimu
Eintrag öffnenAmsparity · 4.8 · Rare post-marketing cases of hepatosplenic T-cell lymphoma have been reported in patients treated with adalimu
Eintrag öffnenAmsparity · 4.8 · Rare post-marketing cases of hepatosplenic T-cell lymphoma have been reported in patients treated with adalimu
Eintrag öffnenAmsparity · 4.8 · The incidence of serious infections was 0.04 per patient year in adalimumab-treated patients and 0.03 per pati
Eintrag öffnen